Skip to main content
Clinical Trials/NL-OMON53227
NL-OMON53227
Recruiting
Not Applicable

The effect of total knee replacement surgery on immune functioning in elderly - Immu-KNEE-ty

Wageningen Universiteit0 sites14 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
immunosenescentie
Sponsor
Wageningen Universiteit
Enrollment
14
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Planned for primary total knee replacement surgery
  • \- Aged 65 years or over
  • \- Diagnosed with osteoarthritis
  • \- ASA Physical Status Classification of II or III
  • \- Scheduled for general anesthesia
  • \- Willing to donate a blood sample at 5 different timepoints
  • \- Able to give written informed consent

Exclusion Criteria

  • \- Daily use of high doses NSAIDs within the 14 days before inclusion: Defined as higher than maintenance dose in the \*farmacotherapeutisch kompas\*. For example: acetylsalicylic acid \> 4 g /day; diclofenac \> 75 mg/day; naproxen \> 500 mg/day; ibuprofen\> 1600 mg/day; celecoxib \> 200 mg/day \- Use of systemic corticosteroids \- Use of antibiotics within the 14 days before inclusion \- Current diagnosis of cancer \- Diagnosed with a primary immunodeficiency disorder (e.g., Severe Combined Immunodeficiency (SCID), Common Variable Immune Deficiency (CVID), X\-linked agammaglobulinemia, selective immunoglobulin A deficiency, chronic granulomatous disease) \- Vaccination (e.g., immunization against COVID\-19, influenza, pneumonia, and travel\-related infections) within the 14 days before inclusion and during the study period \- Current participation in other scientific research

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
How the back pain influences the functional outcome and patient satisfaction after Total knee replacement?Health Condition 1: M170- Bilateral primary osteoarthritis of kneeHealth Condition 2: M472- Other spondylosis with radiculopathy
CTRI/2019/10/021517Ganga medical centre and hospital
Active, not recruiting
Phase 1
Outcome after total knee endoprosthesis under general or regional anesthesia, a randomized studyPatients undego total knee arthroplasty operation in general or spinal anaesthesia because of osteoarthritis, rheumatoid arthritis or other degenerative condition of the kneeMedDRA version: 19.0Level: LLTClassification code 10031174Term: OsteoarthrosisSystem Organ Class: 100000004859MedDRA version: 19.0Level: LLTClassification code 10031158Term: Osteo arthritis kneesSystem Organ Class: 100000004859Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2016-002035-15-FIHelsinki University Central Hospital400
Completed
Not Applicable
The effect of implant design on patient outcomes following total knee replacement
ISRCTN85418379niversity of Edinburgh (UK)204
Completed
Not Applicable
Randomised prospective, double-blinded study comparing the effectiveness of administering morphine patient controlled analgesia (PCA) to morphine and ketamine PCA for patients undergoing a total knee replacement.
ACTRN12613001036707Yoon Leng Ooi530
Completed
Not Applicable
Outcome evaluation of total knee arthroplasty among patients with and without previous high tibial osteotomyKnee arthrosis.Arthrosis, unspecified
IRCT138902053011N1Rasoule Akram Hospital, Orthopedics ward80